AUG 19, 2026 · PHASE 2 TRIAL
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
ClinicalTrials.gov
This is a Phase 2 trial registration with no results reported; the study is still recruiting and no efficacy or safety data are available.
Reported
Planned enrollment30
Study phasePhase 2
Primary outcome measurePreoperative endocrine prognostic index sco…